Pliant Therapeutics, Inc. (PLRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 11.97 |
| Open | 11.83 |
| Bid | 11.78 x 100 |
| Ask | 11.84 x 300 |
| Day's range | 11.67 - 12.03 |
| 52-week range | 10.60 - 22.52 |
| Volume | |
| Avg. volume | 438,030 |
| Market cap | 711.844M |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Pliant Therapeutics First Quarter 2024 Earnings: US$0.78 loss per share (vs US$0.67 loss in 1Q 2023)
Pliant Therapeutics ( NASDAQ:PLRX ) First Quarter 2024 Results Key Financial Results Net loss: US$47.0m (loss widened...
- Zacks
Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline
Pliant Therapeutics, Inc. (PLRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GuruFocus.com
Pliant Therapeutics Inc CFO Keith Cummings Sells 9,781 Shares
Keith Cummings, the CFO of Pliant Therapeutics Inc, sold 9,781 shares of the company on January 17, 2024, according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.